Avast takes $113m equity injection

By

Anti-virus maker wins big.

Anti-virus software maker Avast has received a US$100 million ($113 million) equity injection after Summit Partners took a minority stake in the firm.

Avast takes $113m equity injection

Avast made a popular free anti-virus program with upgrades to premium paid versions.

The company claimed it protected "one out of every five computers around the world from malware".

It had no plans to change its distribution model, although it conceded it hadn't foreseen in the early days the level of demand it would eventually receive for its product.

"When we first launched free distribution of Avast anti-virus in the early 2000s, we gave ourselves room to grow - but never dreamed that the product would gain such global popularity," co-founder Eduard Kucera said.

Add iTnews as your trusted source

Got a news tip for our journalists? Share it with us anonymously here.
Copyright © iTnews.com.au . All rights reserved.
Tags:

Most Read Articles

Chinese Videostrong botnet hit Android TV boxes in Australia: researchers

Chinese Videostrong botnet hit Android TV boxes in Australia: researchers

Binance hackers used fake job interview in US$6.3 billion attack

Binance hackers used fake job interview in US$6.3 billion attack

Tyro finds new CISO

Tyro finds new CISO

Lightweight Linux distros vulnerable to *sshole password bypass

Lightweight Linux distros vulnerable to *sshole password bypass

Log In

  |  Forgot your password?